Inclusion Criteria:  Patients diagnosed with treatment-naïve, active neovascular AMD between January 2017 and December 2017. Patients aged ≥ 50 years old Patients who received intravitreal anti-VEGF injection after the diagnosis  Exclusion Criteria:  - None